Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer
Published date:
09/14/2021
Excerpt:
AGR3 expression exhibited a positive correlation to cell viability. Besides, AGR3 promoted tamoxifen resistance in breast cancer....AGR3 is associated with estrogen and promotes tamoxifen resistance in breast cancer.